alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › population-based-cohort

population-based-cohort

2 studies tagged population-based-cohort, dated 2015-06-01 to 2023-01-31. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study 2023-01-31
  2. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study 2015-06-01

Studies

2 studies carry this tag.

Date range

2015 to 2023

Top journals

  • JAMA psychiatry 1
  • The Lancet regional health. Western Pacific 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. The Lancet regional health. Western Pacific 2023-01-31 Drug development

    From a total of 8026 people (44.3% women, median follow-up time = 756 days), SGLT2i (n = 4231), compared to GLP-1RAs (n = 3795), reduced MACE rates in men (sHR 0.78; 95%CI 0.66-0.93), but not women.

  2. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. JAMA psychiatry 2015-06-01 Treatments

    Depression and DM were independently associated with a greater risk for dementia, and the combined association of both exposures with the risk for all-cause dementia was stronger than the additive association.

All topic tags with their study counts